• News
  • Business
  • Entertainment
  • Sports
  • Lifestyle
  • Technology
  • Elections

News

IndiaWorld

Sports

CricketIPLFootball

Business

Personal FinanceAutoMutual Funds

Entertainment

MoviesCelebrities NewsSouth CinemaOTTMovie Review

Education

JobsResults

Technology

GadgetsChatGPT

Cities

Delhi NCRCrime

Elections

Lifestyle

HealthTravel

Brand Wire

Religion and Spirituality

Astro

Trending

Offbeat

Fact Check

Explainers

Science

Education

HomeTopicBharat
Continues below advertisement

Bharat

News
News
Coronavirus HIGHLIGHTS: Over 2 Crore 'Unutilised' COVID-19 Vaccine Doses Still Available With States, Says Govt
News
Coronavirus HIGHLIGHTS: Goa Govt Allows Bars, Restaurants To Function With 50% Seating Capacity
India
'Would Be A True Tribute': Kejriwal Writes To PM Modi Seeking Bharat Ratna For Doctors, Nurses & ParamedicsĀ 
News
Coronavirus HIGHLIGHTS: Delhi Reports 86 New Covid Cases, 5 Deaths In Last 24 Hours
India
'Covaxin Found To Be 77.8% Effective In Final Analysis Of Phase III Trials', Claims Bharat Biotech
News
Coronavirus HIGHLIGHTS: Zydus Cadila Application For Zycov Jab Under Evaluation, Says Niti Aayog
India
Coronavirus HIGHLIGHTS: Confident Of Getting EMA's Approval In A month For Covishield, Says SII Chief Adar Poonawalla
Health
Covaxin Effectively Neutralises Covid-19's Alpha & Delta Variant: US Health Research Institute
India
'Pricing Clearly Established For Supplies Outside India': Bharat Biotech On Brazil Covaxin Deal Controversy
World
Brazil To Suspend USD 324 Million Covaxin Vaccine Deal Over Accusations Of Irregularities
World
Brazil Govt Faces Probe For Choosing Bharat Biotech's Covaxin Deal Over 'Cheaper' Pfizer Vaccine | All About Controversy
India
Covaxin Phase 3 Trial Data Shows 77.8% Efficacy, Gets Approval From DCGI's Expert Panel
  • 150
  • 151
  • 152
  • 153
  • 154
Continues below advertisement
Sponsored Links by Taboola
About UsFeedbackCareersAdvertise With UsSitemapDisclaimerPrivacy PolicyContact Us
FOLLOW US
This website follows the DNPA Code of Ethics. Copyright@2026. All rights reserved.